Böheimkirchen, Austria

Thomas Weichhart


 

Average Co-Inventor Count = 15.0

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Böheimkirchen, AT (2010 - 2012)
  • Boheimkirchen, AT (2014)

Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Thomas Weichhart: Innovator in Antigen Production

Introduction

Thomas Weichhart is a notable inventor based in Böheimkirchen, Austria. He has made significant contributions to the field of immunology, particularly in the identification and production of antigens for vaccines. With a total of 4 patents to his name, Weichhart's work is pivotal in advancing vaccine development for both humans and animals.

Latest Patents

Weichhart's latest patents focus on methods for the identification, isolation, and production of hyperimmune serum-reactive antigens. These methods are designed to target specific pathogens, tumors, allergens, or tissues prone to autoimmunity. The processes involve providing an antibody preparation, utilizing expression libraries, and screening to identify antigens that bind to antibodies. The patents detail steps for isolating and producing these antigens through chemical or recombinant methods, ensuring their suitability for vaccine use.

Career Highlights

Throughout his career, Thomas Weichhart has worked with prominent companies in the biotechnology sector, including Intercell AG and Valneva Austria GmbH. His experience in these organizations has allowed him to collaborate on innovative projects that enhance vaccine efficacy and safety.

Collaborations

Weichhart has collaborated with several professionals in his field, including Andreas Meinke and Eszter Nagy. These partnerships have contributed to the successful development of his patented methods and have fostered advancements in immunological research.

Conclusion

Thomas Weichhart's contributions to antigen production and vaccine development are invaluable. His innovative methods and collaborations continue to influence the field of immunology, paving the way for future advancements in vaccine technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…